Prospect News: News for Northwest Biotherapeutics, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with N > Issuers starting with N, PP only > All stories on Northwest Biotherapeutics, Inc. > Stories on Northwest Biotherapeutics, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Northwest Biotherapeutics, Inc.

7/5/2016	PP	Northwest negotiates $3.7 million registered direct offering of stock
2/29/2016	PP	Northwest Biotherapeutics negotiates $10 million registered stock sale
12/23/2015	PP	Northwest Biotherapeutics plans $12.6 million registered stock sale
10/21/2015	PP	Northwest Biotherapeutics will conduct $30 million placement of stock
4/2/2015	PP	Northwest Biotherapeutics to raise $40 million via placement of stock
11/19/2014	PP	Northwest Biotherapeutics wraps $25 million private placement of stock
10/7/2014	PP	Northwest Biotherapeutics negotiates $11.5 million placement of stock
8/14/2014	PP	Northwest Biotherapeutics plans $17.5 million convertibles placement
4/14/2014	PP	Northwest Biotherapeutics investor purchases $15 million common stock
4/10/2014	PP	Northwest to conduct $15 million registered direct placement of stock
11/25/2013	PP	Northwest Biotherapeutics greenshoe ups units sale to $27.03 million
11/20/2013	PP	Northwest prices $23.5 million public sale of units at $4.80 per unit
11/19/2013	PP	Northwest Biotherapeutics intends to price public sale of equity units
8/9/2013	PP	Northwest Biotherapeutics plans $15 million placement of stock
4/18/2013	PP	Northwest negotiates $10 million registered direct placement of stock
12/12/2012	PP	Northwest greenshoe fully exercised in $13.8 million public units sale
12/7/2012	PP	Northwest prices $12 million public sale of units at $4.00 per unit
10/3/2012	PP	Northwest concludes $500,000 private placement of 8% convertibles
9/17/2012	PP	Northwest Biotherapeutics sells $833,333 4% two-year convertible note
8/31/2012	PP	Northwest Biotherapeutics wraps $500,000 placement of convertibles
8/23/2012	PP	Northwest completes $1.11 million private placement of 8% convertibles
7/20/2012	PP	Northwest Biotherapeutics seals $1.1 million placement of convertibles
6/29/2012	PP	Northwest Biotherapeutics plans to conduct public offering of stock
5/23/2012	PP	Northwest seals $800,000 of $3 million placement of convertible notes
4/9/2012	PP	Northwest completes $1.3 million of $2.5 million placement of 8% notes
2/15/2012	PP	Northwest Biotherapeutics issues note to Toucan for $2.25 million
2/6/2012	PP	Northwest Biotherapeutics settles $1.61 million sale of convertibles
11/17/2011	PP	Northwest Bio amends $25 million equity sale, plans $2.4 million loans
7/8/2011	PP	Northwest Biotherapeutics completes $4.55 million placement of stock
7/5/2011	PP	Northwest Biotherapeutics seeks $4.55 million from private stock sale
6/6/2011	PP	Northwest Biotherapeutics plans $28 million convertibles, equity sales
1/27/2011	PP	Northwest Biotherapeutics completes $2.22 million convertibles sale
7/7/2010	PP	New Issue: Northwest Biotherapeutics concludes $2.65 million placement of shares
7/7/2010	PP	Market Commentary: AsherXino, iSOFT, Oncothyreon get equity lines; DS Smith closes Ł47.16 million stock placement
4/6/2009	PP	New Issue: Northwest concludes $1.13 million sale of shares, convertibles
11/6/2008	PP	New Issue: Northwest Biotherapeutics sells $1.65 million promissory notes
11/6/2008	PP	Market Commentary: Santhera sells stake to Bertarelli vehicle; Breaker offers stock; Northwest Bio, Penrice Soda wrap deals
10/2/2008	PP	New Issue: Northwest Biotherapeutics arranges $1 million loan with SDS
5/9/2008	PP	Market Commentary: Exactech to reduce debt; GeoPark welcomes new investors; Northwest takes loan; Selwyn sells units
5/9/2008	PP	New Issue: Northwest Biotherapeutics negotiates $4 million loan with Al Rajhi
6/18/2007	PP	New Issue: Northwest Biotherapeutics prices Ł15 million in stock placement
6/4/2007	PP	Northwest Biotherapeutics issues warrants to Toucan Capital
6/4/2007	PP	Northwest Biotherapeutics to conduct private placement for up to $30 million
5/21/2007	PP	Northwest Biotherapeutics plans $30 million private placement of stock
3/31/2006	PP	Market Commentary: Exploration Co. gears up to settle $31.5 million PIPE; oil prices slide but not enough to keep issuers away
3/31/2006	BTPP	New Issue: Northwest Biotherapeutics secures $5.53 million from private placement of stock
2/1/2005	PP	Market Commentary: PIPE volume stalls despite higher stocks; Energy Transfer raises $350 million
2/1/2005	PP	New Issue: Northwest Biotherapeutics raises $1.3 million in private placement of preferreds
11/16/2004	PP	Northwest Biotherapeutics proposes sale of up to $40 million in convertible preferreds
11/16/2004	PP	Market Commentary: Private placements hold steady; Northwest Biotherapeutics may raise $40 million

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.